TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $630M.
  • Teva Pharmaceutical Industries Ltd Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $606M, a 174% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Income Tax Expense (Benefit) for 2023 was -$7M, a 98.9% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Income Tax Expense (Benefit) for 2022 was -$643M, a 405% decline from 2021.
  • Teva Pharmaceutical Industries Ltd annual Income Tax Expense (Benefit) for 2021 was $211M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7M +$636M +98.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 -$643M -$854M -405% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $211M +$379M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 -$168M +$110M +39.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$278M -$83M -42.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 -$195M +$1.74B +89.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 -$1.93B -$2.45B -471% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $521M -$113M -17.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $634M +$43M +7.28% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $591M +$634M Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 -$43M +$94M +68.6% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 -$137M -$264M -208% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $127M -$156M -55.1% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 $283M Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.